Peter Bross

9.1k total citations
150 papers, 6.4k citations indexed

About

Peter Bross is a scholar working on Molecular Biology, Clinical Biochemistry and Cell Biology. According to data from OpenAlex, Peter Bross has authored 150 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Molecular Biology, 62 papers in Clinical Biochemistry and 23 papers in Cell Biology. Recurrent topics in Peter Bross's work include Metabolism and Genetic Disorders (62 papers), Mitochondrial Function and Pathology (44 papers) and Heat shock proteins research (34 papers). Peter Bross is often cited by papers focused on Metabolism and Genetic Disorders (62 papers), Mitochondrial Function and Pathology (44 papers) and Heat shock proteins research (34 papers). Peter Bross collaborates with scholars based in Denmark, United States and Germany. Peter Bross's co-authors include Niels Gregersen, Brage Storstein Andresen, Thomas J. Corydon, Lars Bolund, Rikke Katrine Jentoft Olsen, Jane Christensen, Johan Palmfeldt, Jakob Hansen, Søren Vang and Vibeke Winter and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Peter Bross

148 papers receiving 6.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Bross Denmark 46 4.7k 2.3k 899 855 488 150 6.4k
Niels Gregersen Denmark 47 5.4k 1.2× 3.1k 1.4× 1.2k 1.3× 831 1.0× 435 0.9× 200 7.9k
Leo Nijtmans Netherlands 57 7.4k 1.6× 2.7k 1.2× 618 0.7× 477 0.6× 244 0.5× 108 8.5k
Dieter Brdiczka Germany 46 6.4k 1.4× 1.6k 0.7× 1.6k 1.8× 1.4k 1.6× 572 1.2× 85 8.7k
Michael S. Kilberg United States 46 3.7k 0.8× 1.2k 0.5× 826 0.9× 1.1k 1.3× 112 0.2× 124 6.9k
Katsuyoshi Mihara Japan 55 10.7k 2.3× 2.4k 1.1× 1.5k 1.7× 1.5k 1.7× 353 0.7× 107 12.8k
Holger Prokisch Germany 54 6.6k 1.4× 2.2k 0.9× 598 0.7× 490 0.6× 162 0.3× 221 8.6k
Nika N. Danial United States 35 7.2k 1.5× 664 0.3× 1.1k 1.2× 801 0.9× 255 0.5× 56 10.4k
Rodrigue Rossignol France 44 5.5k 1.2× 994 0.4× 1.3k 1.5× 393 0.5× 175 0.4× 110 7.9k
Anne Lombès France 53 7.1k 1.5× 3.5k 1.5× 982 1.1× 361 0.4× 224 0.5× 145 9.5k
Marc Liesa United States 44 6.5k 1.4× 1.1k 0.5× 2.8k 3.1× 988 1.2× 389 0.8× 83 9.4k

Countries citing papers authored by Peter Bross

Since Specialization
Citations

This map shows the geographic impact of Peter Bross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bross more than expected).

Fields of papers citing papers by Peter Bross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bross. The network helps show where Peter Bross may publish in the future.

Co-authorship network of co-authors of Peter Bross

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bross. A scholar is included among the top collaborators of Peter Bross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bross. Peter Bross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jørgensen, Sofie E., Cagla Cömert, Berit Schiøttz‐Christensen, et al.. (2025). Genetic Landscape and Mitochondrial Metabolic Dysregulation in Patients Suffering From Severe Long COVID. Journal of Medical Virology. 97(3). e70275–e70275.
2.
Santana-Codina, Naiara, Qijia Yu, Cláudia Campos, et al.. (2025). De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. Nature Communications. 16(1). 6987–6987. 1 indexed citations
3.
Thomsen, Emil Aagaard, Johan Palmfeldt, Peter Bross, et al.. (2022). A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer. Oncogene. 41(37). 4271–4281. 26 indexed citations
4.
Cömert, Cagla, Paula Fernández‐Guerra, Magnus Stougaard, et al.. (2022). The psychiatric risk gene BRD1 modulates mitochondrial bioenergetics by transcriptional regulation. Translational Psychiatry. 12(1). 319–319. 3 indexed citations
5.
Hunter, Krystal, et al.. (2021). Clinical characteristics and symptom duration among outpatients with COVID-19. American Journal of Infection Control. 50(4). 383–389. 8 indexed citations
6.
Cömert, Cagla, et al.. (2020). Optimized High-Contrast Brightfield Microscopy Application for Noninvasive Proliferation Assays of Human Cell Cultures. Assay and Drug Development Technologies. 18(5). 215–225. 5 indexed citations
7.
Mosegaard, Signe, et al.. (2020). Riboflavin Deficiency—Implications for General Human Health and Inborn Errors of Metabolism. International Journal of Molecular Sciences. 21(11). 3847–3847. 117 indexed citations
8.
Cömert, Cagla, Lauren Brick, Debbie Ang, et al.. (2020). A recurrent de novo HSPD1 variant is associated with hypomyelinating leukodystrophy. Molecular Case Studies. 6(3). a004879–a004879. 6 indexed citations
9.
Rasmussen, Torsten B., Rune Isak Dupont Birkler, Johan Palmfeldt, et al.. (2018). The clinical outcome of LMNA Missense Mutations can be Associated with the Amount of Mutated Protein in the Nuclear Envelope. European Journal of Heart Failure. 20(10). 1404–1412. 9 indexed citations
10.
Saunders, Carol, Laurie D. Smith, Flemming Wibrand, et al.. (2015). CLPB Variants Associated with Autosomal-Recessive Mitochondrial Disorder with Cataract, Neutropenia, Epilepsy, and Methylglutaconic Aciduria. The American Journal of Human Genetics. 96(2). 258–265. 44 indexed citations
11.
Bross, Peter, et al.. (2014). Proteomic investigation of cultivated fibroblasts from patients with mitochondrial short-chain acyl-CoA dehydrogenase deficiency. Molecular Genetics and Metabolism. 111(3). 360–368. 24 indexed citations
12.
Bross, Peter & Niels Gregersen. (2010). Protein misfolding and cellular stress in disease and aging : concepts and protocols. Humana Press eBooks. 15 indexed citations
13.
Singh, Ripudaman, Steen Kølvraa, Peter Bross, et al.. (2004). Association Between Low Self-Rated Health and Heterozygosity for −110A > C Polymorphism in the Promoter Region of HSP70-1 in Aged Danish Twins. Biogerontology. 5(3). 169–176. 23 indexed citations
14.
Bross, Peter & Niels Gregersen. (2003). Protein misfolding and disease : principles and protocols. Humana Press eBooks. 16 indexed citations
15.
Bross, Peter, et al.. (2003). Protein Quality Control in Endoplasmic Reticulum. Apmis. 111(109). 86–91. 8 indexed citations
16.
17.
Corydon, Thomas J., Cathrine Jespersgaard, Brage Storstein Andresen, et al.. (2000). Human and mouse mitochondrial orthologs of bacterial ClpX. Mammalian Genome. 11(10). 899–905. 33 indexed citations
18.
Ørntoft, Torben F., Else Marie Vestergaard, Eric H. Holmes, et al.. (1996). Influence of Lewis α1-3/4-L-Fucosyltransferase (FUT3) Gene Mutations on Enzyme Activity, Erythrocyte Phenotyping, and Circulating Tumor Marker Sialyl-Lewis a Levels. Journal of Biological Chemistry. 271(50). 32260–32268. 102 indexed citations
19.
Bross, Peter, Thomas G. Jensen, Brage Storstein Andresen, et al.. (1995). Effects of Two Mutations Detected in Medium Chain Acyl-CoA Dehydrogenase (MCAD)-deficient Patients on Folding, Oligomer Assembly, and Stability of MCAD Enzyme. Journal of Biological Chemistry. 270(17). 10284–10290. 75 indexed citations
20.
Gregersen, Niels, Vibeke Winter, A Holmskov, et al.. (1995). Prenatal diagnosis of medium‐chain acyl‐CoA dehydrogenase (MCAD) deficiency in a family with a previous fatal case of sudden unexpected death in childhood. Prenatal Diagnosis. 15(1). 82–86. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niels Gregersen Breakdown of academic impact, for papers by Leo Nijtmans Breakdown of academic impact, for papers by Dieter Brdiczka Breakdown of academic impact, for papers by Michael S. Kilberg Breakdown of academic impact, for papers by Katsuyoshi Mihara Breakdown of academic impact, for papers by Holger Prokisch Breakdown of academic impact, for papers by Nika N. Danial Breakdown of academic impact, for papers by Rodrigue Rossignol Breakdown of academic impact, for papers by Anne Lombès Breakdown of academic impact, for papers by Marc Liesa
Rankless by CCL
2026